XiangQian (XQ) LinFounder

United States - Cambridge, Massachusetts

“For the patients: making the unreasonable reasonable, one step at a time”

Building a global life sciences ecosystem, connecting the US, China and Singapore, across life sciences tools/services and biotech. Personally led over 1B in transactions. Products I developed have cumulative revenues over 1B. Financially independent since age 13. Wharton graduate. Lived and worked in the US, China and Singapore, plus extensive experience in Europe. Proven partner to entrepreneurial scientists. Founder/major shareholder of multiple business platforms:

Esco Lifesciences provides enabling technologies, products and services to the life sciences and healthcare industries, supporting academic research and scientific discoveries, clinical practice, as well as biopharmaceutical R&D and manufacturing. Headquartered in Singapore, Esco has an extensive sales network in over 100 countries, direct sales and service offices in over 20 countries, 8 manufacturing and R&D hubs in the US, Europe, the UK, China, Singapore, and over 1500 employees worldwide. Recently closed a 200M USD Series A round with Vivo Capital, Novo Holdings, CIC, EDBI and other sophisticated investors. Currently the controlling shareholder and serves as Chairman and CEO, grew Esco’s shareholder value >300X.

EVX Ventures, based in Boston/Singapore/Shanghai, builds and invests in biotech companies across Asia and the US. Portfolio companies include Carmine Therapeutics, PairX Bio, Hummingbird Biosciences, Nuevocor, Cargene, Carcell and others. EVX Ventures also invests in US/European biotech companies, bridging them to the Asian markets, especially China and Southeast Asia. Founder/Chairman of EVX Ventures. EVX incubated companies have closed over 1B in follow on funding and pharma partnership deals.

Hiring globally across the Esco / EVX (/portfolio companies) ecosystem. Always looking to connect with world-class talent.